CD4 and neoplasm: The tumor-infiltrating lymphocytes in CRCs consist of anti-tumorigenic CD4+ T cells, such as Th1 or Th22 cells, and pro-tumorigenic CD4+ T cells, such as Th17 or immunosuppressive Tregs [77].